| Mutations: M41L ,D67N , K103N ,Y181C, M184V, G190V, L210W ,T215Y ,P225H L10I, I13V, K20R, M46L, I54V ,T74P, L76V , V82A, I84V, L90M N155H V38A Comorbidities: None Comedications: None Treatment history: None Current regimen: DRV/r (Darunavir-ritonavir/Prezista and Norvir) , TDF/FTC (Truvada) |
Adherence: No options selected CD4: ≤ 200 Viral load: Low (200 - 100,000) HLA-B5701: Negative Tropism: X4 virus |
View results |
Here the patient is on DRV/r twice plus FTC/TDF and have wide spread mutations against RT, Protease Integrase and even Entry inhibitor gp41.
What best would be to be included for this patient ?
1. IBA & DTG
2.FOS & DOR
3.FOS & ENF
4.IBA & RAL
| Regimen | Weighted Score | Active Drugs | Total Pills | Frequency (x/day) |
|---|---|---|---|---|
| DTG+FOS+IBA+TAF/FTC | 7.65 | 3 | 5 | 2 |
| DTG+FOS+IBA+TDF/FTC | 7.75 | 3 | 5 | 2 |
| DTG+FOS+IBA | 7.75 | 2.67 | 4 | 2 |
| DTG+FOS+IBA+DRV/r | 8.4 | 3 | 8 | 2 |
| DTG+FOS+IBA+DRV/r+TAF/FTC | 8.65 | 3.33 | 9 | 2 |